Skip to main content

Table 2 Odds ratios for the risk of uncomplicated peptic ulcer disease associated with patient characteristics and comorbidities (nested case–control analysis)

From: Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular events

 

Controls N = 2000 n (%)

Uncomplicated PUD cases N = 309 n (%)

Adjusted OR (95% CI) a

Sex

  Male

1046 (52.3)

161 (52.1)

NA

  Female

954 (47.7)

148 (47.9)

NA

Age at index date, years

  50-59

250 (12.5)

43 (13.9)

NA

  60-69

575 (28.7)

86 (27.8)

NA

  70-79

859 (43.0)

129 (41.7)

NA

  80-84

316 (15.8)

51 (16.5)

NA

Follow-up time, months

  < 6

211 (10.5)

38 (12.3)

NA

  6-12

227 (11.4)

33 (10.7)

NA

  13-24

335 (16.8)

55 (17.8)

NA

  25-48

538 (26.9)

80 (25.9)

NA

  > 48

689 (34.5)

103 (33.3)

NA

Visits to PCPb

  < 3

62 (3.1)

3 (1.0)

1 (-)

  4-9

544 (27.2)

47 (15.2)

1.35 (0.40-4.52)

  ≥ 10

1394 (69.7)

259 (83.8)

2.03 (0.61-6.76)

Referralsb

  0

466 (23.3)

37 (12.0)

1 (-)

  1-3

834 (41.7)

118 (38.2)

1.46 (0.97-2.20)

  ≥ 4

700 (35.0)

154 (49.8)

1.98 (1.30-3.00)

Hospitalizationsb

  0

1584 (79.2)

213 (68.9)

1 (-)

  ≥ 1

416 (20.8)

96 (31.1)

1.21 (0.90-1.63)

Smoking

  Non-smoker

800 (40.0)

105 (34.0)

1 (-)

  Smoker

267 (13.4)

67 (21.7)

1.96 (1.37-2.80)

  Ex-smoker

892 (44.6)

135 (43.7)

1.01 (0.76-1.34)

  Unknown

41 (2.1)

2 (0.6)

0.48 (0.11-2.08)

BMI, kg/m2

  11-19

67 (3.4)

15 (4.9)

1.11 (0.59-2.11)

  20-24

489 (24.4)

86 (27.8)

1 (-)

  25-29

781 (39.1)

114 (36.9)

0.81 (0.59-1.11)

  ≥ 30

510 (25.5)

80 (25.9)

0.83 (0.59-1.18)

  Unknown

153 (7.6)

14 (4.5)

0.69 (0.37-1.31)

Alcohol use, units per week

  0

88 (4.4)

19 (6.1)

1 (-)

  1-4

377 (18.9)

58 (18.8)

0.67 (0.37-1.21)

  5-15

395 (19.8)

56 (18.1)

0.64 (0.35-1.17)

  ≥ 16

148 (7.4)

22 (7.1)

0.65 (0.31-1.32)

  Unknown

992 (49.6)

154 (49.8)

0.66 (0.38-1.16)

Practice location

  Rural

235 (6.8)

7 (2.3)

1 (-)

  Urban

1382 (69.1)

233 (75.4)

3.21 (1.46-7.04)

  Town

240 (12.0)

28 (9.1)

2.38 (1.00-5.68)

  Unknown

243 (12.2)

41 (13.3)

2.75 (1.18-6.42)

Townsend deprivation index

  1 (least deprived)

489 (24.4)

59 (19.1)

1 (-)

  2

435 (21.8)

55 (17.8)

1.09 (0.73-1.63)

  3

411 (20.5)

68 (22.0)

1.29 (0.88-1.90)

  4

382 (19.1)

68 (22.0)

1.35 (0.91-1.99)

  5 (most deprived)

54 (17.5)

54 (17.5)

1.56 (1.01-2.39)

  Unknown

5 (1.6)

5 (1.6)

0.52 (0.20-1.37)

Comorbidities

  Cerebrovascular diseasec

629 (31.5)

91 (29.4)

0.89 (0.68-1.17)

  Ischaemic heart diseasec

1382 (69.1)

221 (71.5)

1.07 (0.81-1.41)

  Myocardial infarctionc

514 (25.7)

97 (31.4)

1.26 (0.96-1.66)

  Hypertensionc

1223 (61.2)

180 (58.3)

0.82 (0.63-1.06)

  Hyperlipidaemiac

697 (34.9)

114 (36.9)

1.08 (0.83-1.41)

  Diabetes mellitusc

328 (16.4)

60 (19.4)

1.08 (0.78-1.50)

  Goutc

176 (8.8)

22 (7.1)

0.70 (0.43-1.14)

  Rheumatoid arthritisc

55 (2.8)

20 (6.5)

1.46 (0.83-2.58)

  Osteoarthritisc

858 (42.9)

157 (50.8)

1.13 (0.87-1.46)

  COPDc

158 (7.9)

34 (11.0)

1.08 (0.71-1.65)

  Asthmac

324 (16.2)

54 (17.5)

0.82 (0.59-1.15)

  Anaemiac

177 (8.8)

70 (22.7)

2.53 (1.82-3.53)

  Stressc

158 (7.9)

42 (13.6)

1.58 (1.06-2.33)

  Anxietyc

351 (17.6)

70 (22.7)

1.21 (0.89-1.64)

  Depressionc

474 (23.7)

103 (33.3)

1.38 (1.04-1.83)

  IBSc

129 (6.5)

25 (8.1)

1.06 (0.66-1.71)

  GERDc

280 (14.0)

60 (19.4)

1.13 (0.81-1.57)

  Uncomplicated PUD symptomsd

471 (23.6)

133 (43.0)

2.09 (1.56-2.81)

  1. aOR adjusted for age, sex, follow-up time, health service utilization (PCP visits and referrals), smoking and drug use during the study period (gastroprotective drugs, NSAIDs, ASA and paracetamol).
  2. bIn year before the index date.
  3. cDiagnosed before the index date. Relative to being free from the comorbidity.
  4. dDiagnosed between the start date and the index date. Relative to being free from symptoms.
  5. Abbreviations: ASA-Acetylsalicylic acid; BMI-Body mass index; CI-Confidence interval; COPD-Chronic obstructive pulmonary disease; GERD-Gastroesophageal reflux disease; IBS-Irritable bowel syndrome; NA-Not assessed; NSAIDs-Non-steroidal anti-inflammatory drugs; OR-Odds ratio; PCP-Primary care physician; PUD-Peptic ulcer disease.